CLICK ON REPORT TITLE TO VIEW MORE DETAILS • 3D Printing for Healthcare: R&D, Industry and Market

2014-2024 Published 17 January 2014

• Advanced Wound Care: World Market Forecast 2014-2024 & Future Prospects for Leading Companies Published 05 February 2014

• Alzheimer’s Disease Therapeutics and Diagnostics: World Market 2013-2023 Published 17 June 2013

• Antibacterial Drugs: World Industry and Market Prospects 2014-2024 Published 04 March 2014

• Antiemetic Drugs: World Industry and Market Analysis 2014-2024 Published 19 May 2014

• Antithrombotic Drugs: World Industry and Market Prospects 2014-2024 Published 19 February 2014

• Asthma and COPD Therapies World Market 2013-2023 Published 06 September 2013

• Biobanking for Medicine: Technology, Industry and Market 2014-2024 Published 25 March 2014

• Biomarkers: Technological and Commercial Outlook 2013-2023 Published 23 July 2013

• Biosimilar Monoclonal Antibodies: World Market Prospects 2013-2023 Published 10 April 2013

• Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 Published 01 May 2014

• Biotech API Manufacturing Services: World Industry and Market 2014-2024 Published 12 December 2013

• Bleeding Disorders: World Pharmaceutical Industry and Market 2014-2024 Published 09 December 2013

• Brazilian Pharmaceutical Market 2014-2024 Published 21 November 2013

• Chinese Pharmaceutical Market: Forecasts and Outlooks 2014-2024 Published 25 July 2014

• Dermatological Drugs Market Forecast 2014-2024: Future Prospects for Leading Companies Published 15 April 2014

• Diabetes Treatments: World Drug Market 2013-2023 Published 24 April 2013

• Drug Discovery Outsourcing World Market Forecast 2014-2024 & Future Prospects for Leading Companies Published 13 January 2014

• Epigenetic R&D, Therapies and Diagnostics: Industry and Market Prospects 2014-2024 Published 16 June 2014

• Generic Drugs: World Market 2014-2024 & Future Prospects for Leading Companies Published 20 February 2014

• Hepatitis Drugs and Vaccines: World Market 2013-2023 Published 21 June 2013

• Inflammatory Bowel Diseases: World Drug Market 2013-2023 Published 17 July 2013

• Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024 Published 09 June 2014

• Leading Anti-Cancer Drugs and Associated Market 2013-2023 Published 11 June 2013

• Lyophilisation for Pharmaceuticals: Products and Services 2014-2024 & Future Prospects for Leading Companies Published 11 February 2014

• Macular Degeneration (AMD) and Other Retinal Diseases: World Drug Market 2014-2024 Published 02 December 2013

• Mobile Health (mHealth) Market Forecast 2014-2024: A Revolution in eHealth, Telemedicine, Informatics & Connected Health Published 18 July 2014

• Multiple Myeloma Treatments: World Drug Industry and Market 2013-2023 Published 24 October 2013

• Multiple Sclerosis Treatment: World Drug Market 2012-2022 Published 23 November 2011

• Neuroprotective Products: World Market Prospects 2012-2022 Published 10 May 2012

• Next-Generation Antibody Therapies: World Industry and Market 2014-2024 Published 24 February 2014

• Next-Generation Biologics: R&D, Industry and Market 2014-2024 Published 02 April 2014

• Ophthalmic Drugs Market Forecast 2014-2024 Published 16 June 2014

• Orphan Drugs for Cancer: R&D and Market 2013-2023 Published 29 July 2013

• Orphan Drugs for CNS Diseases: R&D and Market 2014-2024 Published 10 January 2014

• Ortho and Osteobiologics: World Industry and Market Analysis 2014-2024 Published 27 January 2014

• Osteoporosis Treatment and Prevention: World Drug Market Forecast 2014-2024 & Future Prospects for Leading Companies Published 21 May 2014

• Parkinson’s Disease: World Drug Industry and Market 2014-2024 Published 04 February 2014

• Pharma Clinical Trial Services: World Market 2013-2023 Published 25 January 2013

• Pharma Contract Manufacturing: World Market Outlook 2013-2023 Published 11 September 2013

• Pharma Leader Series: Top 20 Antibacterial Drug Manufacturers 2012-2022 Published 21 June 2012

• Pharma Leader Series: Top 20 Biological Drug Manufacturers 2012-2022 Published 10 September 2012

• Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2014-2024 Published 22 January 2014

• Pharma Leader Series: Top 25 Biosimilar Drug Manufacturers 2013-2023 Published 19 September 2013

• Pharma Leader Series: Top 50 Generic Drug Manufacturers 2013-2023 Published 04 July 2013

• Pharma Leader Series: Top Pharma Contract Manufacturing Organisations (CMOs) 2013-2023 Published 01 July 2013

• Pharma Leader Series: Top Stem Cell Technology Companies 2014-2024 Published 17 March 2014

• Pharma Wholesale and Distribution Market: World Outlook 2013-2023 Published 03 June 2013

• Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2014-2024 Published 18 November 2013

• Pharmaceutical Contract Manufacturing: World Market Outlook 2012-2022 Published 20 August 2012

• Pharmacovigilance and Related Developments: Industry and Market Analysis 2014-2024 Published 10 April 2014

• Psoriasis Treatment: World Drug Market 2013-2023 Published 05 September 2013

• Rheumatoid Arthritis (RA): World Drug Market 2013-2023 Published 19 April 2013

• RNAi for Therapeutic Applications: Technology and Market 2014-2024 Published 12 February 2014

• Single-Use Bioreactors for Pharma: World Market 2013-2023 Published 03 June 2013

• Small-Molecule Targeted Cancer Therapies: World Market 2013-2023 Published 10 December 2012

• Smoking Cessation Drugs: World Market Prospects 2013-2023 Published 26 September 2013

• Stem Cell Technologies: World Market Outlook 2013-2023 Published 02 August 2013

• The Prostate Cancer Therapeutics Market Forecast 2014-2024: Opportunities for Leading Companies Published 18 July 2014

• Top 20 Mobile Health (mHealth) Companies 2014: Leading Competitors in eHealth, Telemedicine & Health informatics Published 05 December 2013

• Translational Regenerative Medicine: Market Prospects 2014-2024 Published 25 November 2013

• Vaccine Manufacturing Technology and Services: World Market Forecast 2014-2024: Prospects For Leading Players Published 11 March 2014

• World Biological Drugs Market 2013-2023 Published 13 May 2013

• World OTC Pharmaceutical Market 2013-2023 Published 10 October 2013

• World Pain Relieving Drug Market 2013-2023 Published 24 July 2013

• World Pharma Contract Sales Industry and Market: Predictions 2014-2024 Published 06 February 2014

• World Pharmaceutical Contract Sales Market 2013-2023 Published 06 November 2012

• World Vaccines Market 2013-2023 Published 08 October 2013

The Prostate Cancer Therapeutics Market Forecast 2014-2024: Opportunities for Leading CompaniesOur 208-page report provides 160 tables, charts, and graphs. Our new study lets you assess leading drugs and devices in the prostate cancer therapeutics market, showing their prospects to 2024. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and national level. You will see financial results, interviews, trends, opportunities, and revenue predictions. Much opportunity remains in this growing pharma market.

Published 18 July 2014

https://www.visiongain.com/Report/1294/The-Prostate-Cancer-Therapeutics-Market-Forecast-2014-2024

Chinese Pharmaceutical Market: Forecasts and Outlooks 2014-2024Medical revenues in China – your guide to trends, companies and potentials. What’s the outlook for the Chinese

pharma market? Can it sustain high growth? Visiongain’s updated report gives you forecasted revenues there to 2024. That work explains medical and technological trends, prospects and commercial opportunities. Our report predicts overall pharma sales in China will reach $97.4bn in 2014, expanding onwards to 2024. See

what’s possible.

Published 25 July 2014

https://www.visiongain.com/Report/1298/Chinese-Pharmaceutical-Market-Forecasts-and-Outlooks-2014-2024

Epigenetic R&D, Therapies and Diagnostics: Industry and Market Prospects 2014-2024Epigenetics market – new analysis showing you technological trends and sales forecasts. Do you want to find sales potentials of epigenetic technologies, diagnostics and medicines? Now get the latest analysis for that industry. There you explore developments (R&D), results, opportunities, trends and revenue forecasts. Visiongain’s updated report shows you what’s possible for those drugs, diagnostic tests and related technology.

Published 25 June 2014

https://www.visiongain.com/Report/1284/Epigenetic-R-D-Therapies-and-Diagnostics-Industry-and-Market-Prospects-2014-2024

Mobile Health (mHealth) Market Forecast 2014-2024: A Revolution in eHealth, Telemedicine, Informatics & Connected Health

mHealth is a term used for the practice of medicine and health services, through mobile devices. In its most common form, it refers to using mobile communication devices, such as smartphones and tablets, for health

services and information. mHealth applications include the use of mobile devices in collecting community and clinical health data, delivery of healthcare information to practitioners, researchers, and patients, real-time

monitoring of patient vital signs, and direct provision of care, via mobile telemedicine. Visiongain forecasts the mHealth market to reach a $6.7 billion value by the end of 2014.

Published 18 July 2014

https://www.visiongain.com/Report/1295/Mobile-Health-(mHealth)-Market-Forecast-2014-2024

Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024Do you want to find sales potentials of kinase inhibitors? Now get the latest analysis for those cancer treatments. There you explore developments, other trends, results, opportunities and revenue forecasts. Visiongain’s new report shows you what’s possible for drugs using protein kinase inhibition and related technology. There avoid missing out in data. Instead find progress in that industry and market, discovering expected advances and sales. See now how you can gain.

Published 09 June 2014

https://www.visiongain.com/Report/1275/Kinase-Inhibitors-for-Treating-Cancer-Industry-Analysis-R-D-Trends-and-World-Market-Forecasts-2014-2024

Ophthalmic Drugs Market Forecast 2014-2024

Where is the ophthalmic drugs market heading? Visiongain’s brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and prospects there. Our 337 page report provides 198 tables,

charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and national level. You will see financial

results, interviews, trends, opportunities, and revenue predictions. Much opportunity remains in this growing pharma market.

Published 16 June 2014

https://www.visiongain.com/Report/1279/Ophthalmic-Drugs-Market-Forecast-2014-2024

Antiemetic Drugs: World Industry and Market Analysis 2014-2024Treatments for nausea and vomiting – explore business trends, R&D, and revenue forecasts. What’s the future of treating nausea and vomiting? For those medicines you get sales predictions, also exploring research and development. Those treatments hold high potential. There you assess results, progress, therapies, and opportunities. Visiongain’s new report forecasts those revenues to 2024 at overall world market, submarket, product, and national level. Discover business potentials – trends, technologies, and new drugs.

Published 19 May 2014

https://www.visiongain.com/Report/1263/Antiemetic-Drugs-World-Industry-and-Market-Analysis-2014-2024

Osteoporosis Treatment and Prevention: World Drug Market Forecast 2014-2024 & Future Prospects for Leading Companies

Osteoporosis drugs – new study showing you trends, R&D progress, and predicted revenues. Where’s the osteoporosis drugs market heading? Visiongain’s brand new report shows you potential revenues to 2024,

assessing data, trends, opportunities and prospects there.

Published 21 May 2014

https://www.visiongain.com/Report/1267/Osteoporosis-Treatment-and-Prevention-World-Drug-Market-Forecast-2014-2024-Future-Prospects-for-Leading-Companies

Dermatological Drugs Market Forecast 2014-2024: Future Prospects for Leading CompaniesDermatological drugs – new study showing you trends, R&D progress, and predicted revenues. Where’s the dermatological drugs market heading? Visiongain’s brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and prospects there.

Published 15 April 2014

https://www.visiongain.com/Report/1242/Dermatological-Drugs-Market-Forecast-2014-2024

Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024

Biosimilar drugs – discover trends and segments with highest potential revenues. Do you want to find sales potentials of biosimilars? Visiongain’s updated report gives you revenue predictions for those biological drugs from 2014, helping you stay ahead. For those therapies you find financial data, R&D trends, opportunities and

selling prospects.

Published 01 May 2014

https://www.visiongain.com/Report/1253/Biosimilars-and-Follow-On-Biologics-World-Industry-and-Market-Prospects-2014-2024

Next-Generation Biologics: R&D, Industry and Market 2014-2024What’s the future of biologics, especially new drug classes? Now get the latest technological and commercial analysis. Staying ahead in data and knowledge, you benefit your authority. And you explore trends, developments, results, opportunities, and sales predictions. So visiongain’s new report shows you what’s possible for biological drugs – their next phase. There avoid missing out. Instead find progress in that industry and market, discovering expected progress and revenues. See now how you can gain. New biotechnological medicines will benefit patients and pharmaceutical companies. Read on to explore those therapies, hearing how high revenues can go.

Published 02 April 2014

https://www.visiongain.com/Report/1235/Next-Generation-Biologics-R-D-Industry-and-Market-2014-2024

Pharmacovigilance and Related Developments: Industry and Market Analysis 2014-2024

Where are pharmacovigilance and related needs heading? For those pharmaceutical testing studies you get new analysis, also exploring sales predictions. You unlock that medical industry. And you assess its results, trends, technologies, prospects, and opportunities. Visiongain’s updated report forecasts those revenues to 2024 at

overall world market, regional, and national level. There stay ahead in data, benefiting your influence. And hear about gains for patients, doctors, healthcare providers, and companies.

Published 10 April 2014

https://www.visiongain.com/Report/1239/Pharmacovigilance-and-Related-Developments-Industry-and-Market-Analysis-2014-2024

Pharma Leader Series: Top Stem Cell Technology Companies 2014-2024Stem cell developers and producers - discover companies’ R&D and revenue prospects. Who are the top stem cell developers and producers? And what are their sales potentials? Visiongain’s new report shows you their outlooks from 2014. There you discover therapies, sales results, trends, opportunities, and predictions of revenues. That way you find data and analysis on cellular technologies with potential to improve human medicine. Our study analyses 22 leading companies in the US, Europe, Israel, and Asia. There you hear how stem cell producers can gain and progress, discovering what’s possible.

Published 17 March 2014

http://www.visiongain.com/Report/1223/Pharma-Leader-Series-Top-Stem-Cell-Technology-Companies-2014-2024

Biobanking for Medicine: Technology, Industry and Market 2014-2024

Biobanks - how to find business trends, R&D, and revenue forecasts. What does the future hold for medical biobanks? Now you get technological and commercial predictions from 2014. Stay ahead, then, for data, helping your authority. There you explore developmental trends, sales results, opportunities, and revenue

forecasts. That new report by visiongain shows you what’s possible for biobanking and associated technology to improve healthcare. Avoid missing out. Instead find prospects for that biomedical industry and market,

discovering expected trends, progress and gains.

Published 25 March 2014

https://www.visiongain.com/Report/1229/Biobanking-for-Medicine-Technology-Industry-and-Market-2014-2024

Antibacterial Drugs: World Industry and Market Prospects 2014-2024Antibacterials - new analysis showing business trends, R&D, and revenue forecasts. What’s the future of medicines treating bacterial infections? For those drugs you get new sales predictions, also exploring research and development. Those treatments hold high potentials. There you assess results, progress, therapies, and opportunities. Knowledge facilitates success. Visiongain’s new report forecasts those revenues to 2024 at overall world market, submarket, product, and national level. There you stay ahead in data on microbial diseases, finding commercial prospects to benefit your influence.

Published 04 March 2014

http://www.visiongain.com/Report/1215/Antibacterial-Drugs-World-Industry-and-Market-Prospects-2014-2024

Vaccine Manufacturing Technology and Services: World Market Forecast 2014-2024: Prospects For Leading Players

Vaccine manufacturing technology and services - your guide to trends and revenue prospects for vaccine production. What’s the outlook for producing vaccines? Visiongain’s brand new report shows you the potential

revenues to 2024, assessing data, trends, opportunities and prospects there. Our 205 page report provides 104 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our

new study lets you assess forecasted sales at overall world market, submarket and national level. You will see financial results, interviews, trends, opportunities, and revenue predictions.

Published 11 March 2014

http://www.visiongain.com/Report/1221/Vaccine-Manufacturing-Technology-and-Services-World-Market-Forecast-2014-2024

Generic Drugs: World Market 2014-2024 & Future Prospects for Leading CompaniesGeneric drugs - new study showing you trends, R&D progress, and predicted revenues. Where’s the generic drugs market heading? Visiongain’s brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and prospects there. Our 238 page report provides 154 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and national level. You will see financial results, interviews, trends, opportunities, and revenue predictions. As pharma patents expire, much opportunity remains.

Published 20 February 2014

http://www.visiongain.com/Report/1209/Generic-Drugs-World-Market-2014-2024

Next-Generation Antibody Therapies: World Industry and Market 2014-2024

Antibody technology - discover R&D, business analysis, and revenue forecasts. What’s the future of technologies harnessing therapeutic antibodies? Now you can get technological and business predictions. Stay ahead for

data, helping your authority. There you explore developmental trends, sales results, opportunities, and revenue forecasts. Visiongain’s new report shows you what’s possible for monoclonal antibodies (mAbs) and other

immunotechnology for pharmaceuticals. Avoid missing out. Instead find progress in that medical industry and market, discovering the expected progress and gains.

Published 24 February 2014

http://www.visiongain.com/Report/1210/Next-Generation-Antibody-Therapies-World-Industry-and-Market-2014-2024

RNAi for Therapeutic Applications: Technology and Market 2014-2024Potential of RNAi therapies - new analysis showing R&D, trends, and revenue prospects. Where are RNA interference based medicines going? For those treatments you can get new sales predictions and explore developments. You unlock that emerging medical industry. And you assess its results, trends, technologies, potentials, and opportunities. Visiongain’s new report forecasts those revenues to 2024 at overall world market, product, and national level. Discover now what’s happening. You stay ahead in data, then, helping your influence. Hear about potential gains for companies pioneering those drugs.

Published 12 February 2014

http://www.visiongain.com/Report/1204/RNAi-for-Therapeutic-Applications-Technology-and-Market-2014-2024

Antithrombotic Drugs: World Industry and Market Prospects 2014-2024

Treating thrombosis - new analysis showing trends, R&D, and revenue forecasts. See the future of antithrombotic medicines. For those treatments you can get new sales predictions, also exploring research and development. Discover business potentials. And you assess results, trends, technologies, therapies, and

opportunities. Visiongain’s report forecasts those revenues to 2024 at overall world market, submarket, product, and national level. You stay ahead in data on treating thrombotic disorders, finding commercial prospects to

benefit your influence.

Published 19 February 2014

http://www.visiongain.com/Report/1208/Antithrombotic-Drugs-World-Industry-and-Market-Prospects-2014-2024

World Pharma Contract Sales Industry and Market: Predictions 2014-2024Outsourced selling of medicines - how to find trends, opportunities, and revenue prospects. What’s the future of outsourcing pharma sales activities? Now you can get new forecasts for contracted promotional activities for prescription drugs. Stay ahead, then, for data. There you explore business results, developments, trends, opportunities, and predicted revenues. Visiongain’s new report shows you what’s possible in those services for pharmaceuticals. Avoid missing out or losing authority. Instead you get financial analysis for that industry and market, discovering outlooks. Find progress in detailing and hear about the expected gains.

Published 06 February 2014

http://www.visiongain.com/Report/1199/World-Pharma-Contract-Sales-Industry-and-Market-Predictions-2014-2024

Lyophilisation for Pharmaceuticals: Products and Services 2014-2024 & Future Prospects for Leading Companies

Lyophilisation for pharmaceuticals - discover trends and segments with highest revenue potential. What are the commercial prospects for pharmaceutical freeze-drying? Visiongain’s brand new report shows you potential

revenues to 2024, assessing data, trends, opportunities and prospects there. Our new study lets you assess projected sales at world market, submarket and national level to 2024. You will see financial results, interviews, trends, opportunities, and revenue predictions. In our investigation you also see qualitative analyses, news, R&D

and business developments. Also, you see qualitative analyses (SWOT, PESTEL and Porter’s Five Forces).

Published 11 February 2014

http://www.visiongain.com/Report/1202/Lyophilisation-for-Pharmaceuticals-Products-and-Services-2014-2024

Parkinson’s Disease: World Drug Industry and Market 2014-2024Treating Parkinson’s - how you find business trends, R&D, and revenue forecasts. See the future of Parkinson’s drugs. For those treatments you can get new sales predictions, also exploring research and development. You unlock that CNS medical industry. And you assess its results, trends, technologies, therapies, and opportunities. Visiongain’s report forecasts those revenues to 2024 at overall world market, submarket, product, and national level. You stay ahead in data, then, finding commercial prospects. And you hear about gains for companies, doctors, and patients, also benefiting your influence.

Published 04 February 2014

http://www.visiongain.com/Report/1195/Parkinson’s-Disease-World-Drug-Industry-and-Market-2014-2024

Advanced Wound Care: World Market Forecast 2014-2024 & Future Prospects for Leading Companies

Advanced wound care - assess products, developments, and revenue prospects. What does the future hold for the advanced wound care market? Visiongain’s brand new report shows you potential revenues to 2024,

assessing data, trends, opportunities and prospects there. Our 196 page report provides 176 tables, charts, and graphs covering 25 distinct submarket segments. Discover the most lucrative areas in the industry and the future

market prospects. You will see financial results, interviews, trends, opportunities, and revenue predictions.

Published 05 February 2014

http://www.visiongain.com/Report/1198/Advanced-Wound-Care-World-Market-Forecast-2014-2024

Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2014-2024New study shows you commercial prospects for leading eye drug producers. What does the future hold for top companies in the pharma ophthalmics industry? Visiongain’s brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and prospects there. Our 235 page report provides 152 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. We analyse the 38 leading companies for eye medicines, to help you see the future of that industry and market. You will see financial results, interviews, trends, opportunities, and revenue predictions.

Published 22 January 2014

http://www.visiongain.com/Report/1186/Pharma-Leader-Series-Top-25-Ophthalmic-Drug-Manufacturers-2014-2024

Ortho and Osteobiologics: World Industry and Market Analysis 2014-2024

Biotechnology for bone disorders - new study showing you trends, R&D progress, and predicted revenues. What’s the future of orthobiologics and osteobiologics? Visiongain’s updated report gives you predictions for those medical devices and pharmaceuticals. There you explore sales results, technologies, needs, R&D, opportunities, and revenue forecasts. So see what’s possible for those bone-repairing agents and related

biotechnologies for bone diseases. You gain data and financial analysis for that industry. There find technological progress and commercial prospects for technology and medicines. Discover potential gains.

Published 27 January 2014

http://www.visiongain.com/Report/1188/Ortho-and-Osteobiologics-World-Industry-and-Market-Analysis-2014-2024

Drug Discovery Outsourcing World Market Forecast 2014-2024 & Future Prospects for Leading CompaniesDrug discovery outsourcing - discover trends and segments with highest revenue potential. What does the future hold for drug discovery outsourcing? Visiongain’s brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and prospects there. Our new study is your guide to the potential of those pharmaceutical services. It lets you assess projected sales at world market, submarket and regional level to 2024. You will see financial results, interviews, trends, opportunities, and revenue predictions.

Published 13 January 2014

http://www.visiongain.com/Report/1180/Drug-Discovery-Outsourcing-World-Market-Forecast-2014-2024

3D Printing for Healthcare: R&D, Industry and Market 2014-2024Printing in three dimensions for medicine - this new analysis explains trends, technologies, and sales potentials.

What’s the future of additive manufacturing for medicine? That’s fabricating three dimensional solid objects from digital models, via 3D printers. Visiongain’s new report gives data you need there, letting you explore

developments, technology, and revenue predictions. That analysis forecasts revenues there to 2024 at overall world market, submarket, and national level.

Published 17 January 2014

http://www.visiongain.com/Report/1184/3D-Printing-for-Healthcare-R-D-Industry-and-Market-2014-2024

Biotech API Manufacturing Services: World Industry and Market 2014-2024Outsourced biopharma production - new analysis announcing revenue prospects. What’s the outlook for making biological active pharma ingredients (APIs) under contract? Visiongain’s new report gives you predictions of those revenues from 2014. There you see financial data, also assessing trends, technologies, clients’ needs, and opportunities. That study gives you sales forecasts to 2024 at overall world market, submarket, and national level. Discover, then, what’s happening for those production services - outsourcing and off-shoring for biomedicines. There you stay ahead in commercial knowledge.

Published 12 December 2013

http://www.visiongain.com/Report/1169/Biotech-API-Manufacturing-Services-World-Industry-and-Market-2014-2024

Orphan Drugs for CNS Diseases: R&D and Market 2014-2024Uncommon nerve disorders - new study explains technological and commercial prospects. What’s the future of medicines for rare central nervous system (CNS) disorders? Visiongain’s new report gives you predictions

for those therapies. Stay ahead. There you explore sales results, technologies, R&D trends, opportunities, and revenue forecasts.

Published 10 January 2014

http://www.visiongain.com/Report/1178/Orphan-Drugs-for-CNS-Diseases-R-D-and-Market-2014-2024

Top 20 Mobile Health (mHealth) Companies 2014: Leading Competitors in eHealth, Telemedicine & Health informaticsThe potential benefits of mobile health (mHealth) solutions range from improving healthcare system processes, from appointment booking software to the retrieval of crucial data, to patients being able to manage chronic conditions better with the help of mHealth apps on their mobile devices. Mobile communications can also transform how subscribers who live in remote or rural areas access health advice and how patients in these areas communicate with their health care practitioners.

Published 05 December 2013

http://www.visiongain.com/Report/1165/Top-20-Mobile-Health-(mHealth)-Companies-2014

Bleeding Disorders: World Pharmaceutical Industry and Market 2014-2024

Treating abnormal bleeding - this new report shows you trends, R&D outlooks, and sales forecasts. Treatments for bleeding - what’re their prospects? Visiongain’s new report gives you predictions for drugs controlling those blood clotting diseases. Stay ahead then. You discover financial results, technologies, R&D trends, opportunities,

and forecasted revenues.

Published 09 December 2013

http://www.visiongain.com/Report/1167/Bleeding-Disorders-World-Pharmaceutical-Industry-and-Market-2014-2024

Translational Regenerative Medicine: Market Prospects 2014-2024Our new study shows you the commercial potential of regenerative treatments. What does the future hold for regenerative medicine? Visiongain’s brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and prospects there. Our study lets you assess regenerative medicine: cell-based therapies that aim to restore function and regenerate diseased tissues. It lets you assess projected sales at world market, market segment, product and regional level to 2024. You will see financial results, interviews, trends, opportunities, and revenue predictions.

Published 25 November 2013

http://www.visiongain.com/Report/1159/Translational-Regenerative-Medicine-Market-Prospects-2014-2024

Macular Degeneration (AMD) and Other Retinal Diseases: World Drug Market 2014-2024

What’s the future for treating disorders of the retina? Visiongain’s updated report forecasts those pharma revenues. There you find outlooks for sales growth in that industry. You also explore trends, technologies,

therapies, and opportunities. That analysis gives you predictions of revenues to 2024 at overall world market, submarket, product, and national level. Avoid falling behind in data, then, missing business or losing influence.

So find what’s happening for those ocular medicines. Discover how you can gain.

Published 02 December 2013

http://www.visiongain.com/Report/1163/Macular-Degeneration-(AMD)-and-Other-Retinal-Diseases-World-Drug-Market-2014-2024

Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2014-2024Your guide to developments, opportunities and revenues. Where is the pharmaceutical anti-counterfeiting industry heading? Visiongain’s brand new report lets you assess forecasted sales at overall world market, submarket, and national level to 2024. Our 169 page study investigates technologies to tackle drug counterfeiters. Discover the most lucrative areas in that industry and market, seeing future outlooks.

Published 18 November 2013

http://www.visiongain.com/Report/1154/Pharmaceutical-Anti-counterfeiting-Technologies-Market-Analysis-2014-2024

Brazilian Pharmaceutical Market 2014-2024Drug selling in Brazil - this new analysis shows you trends, opportunities, and revenues. Do you want to assess the future of pharmaceuticals in Brazil? See what lies ahead, then. Visiongain’s new report gives you revenue predictions, helping your work. There you discover financial results, trends, opportunities, and sales forecasts.

So you see what’s possible for that trade. Get data to 2024 for the drugs industry operating there. You find business analysis, trends, prospects, and potential revenues.

Published 21 November 2013

http://www.visiongain.com/Report/1157/Brazilian-Pharmaceutical-Market-2014-2024

World OTC Pharmaceutical Market 2013-2023What does the future hold for OTC medicines? Visiongain’s report shows you potential revenues to 2023, assessing data, trends, opportunities and prospects there. Our study lets you assess OTC (over-the-counter) pharmaceuticals: medicines sold without prescriptions. It lets you assess projected sales at world market, therapeutic submarket, product and national level to 2023. There you see financial results, interviews, trends, opportunities, and revenue predictions.

Published 08 October 2013

http://www.visiongain.com/Report/1125/World-OTC-Pharmaceutical-Market-2013-2023

Multiple Myeloma Treatments: World Drug Industry and Market 2013-2023

Myeloma medicines - now discover R&D trends, opportunities, and potential revenues. What are the commercial prospects for treating multiple myeloma? Visiongain’s updated report gives you predictions, helping you stay

ahead. There you see financial results, technological developments, opportunities, and commercial outlooks. In that new analysis you discover sales forecasts to 2023 at overall world market, submarket, product, and national level for those drugs. You also assess technologies, competition, and progress for treating that cancer. There find

data and potentials.

Published 24 October 2013

http://www.visiongain.com/Report/1144/Multiple-Myeloma-Treatments-World-Drug-Industry-and-Market-2013-2023

Smoking Cessation Drugs: World Market Prospects 2013-2023How much revenue can medicines to treat smoking generate? Visiongain’s updated report gives you predictions, helping you stay ahead. There you see financial results, R&D trends, opportunities, and commercial potential. In that new study you discover forecasted sales to 2023 at overall world market, submarket, product, and national level. You also assess technologies, competition, and expected developments for treating tobacco addiction. Find prospects there.

Published 26 September 2013

http://www.visiongain.com/Report/1118/Smoking-Cessation-Drugs-World-Market-Prospects-2013-2023

World Vaccines Market 2013-2023Vaccines and their technology - your guide to developments, opportunities, and revenues. See what the

future holds for vaccines. Visiongain’s updated report lets you assess forecasted sales at overall world market, submarket, product, and national level to 2023. Make sure you understand trends, R&D, opportunities, and

prospects there, in human medicine, helping your research, analyses, and decisions. Discover in our work what’s likely to happen for those technologies. You find there how you can benefit.

Published 08 October 2013

http://www.visiongain.com/Report/1126/World-Vaccines-Market-2013-2023

Pharma Contract Manufacturing: World Market Outlook 2013-2023Where’s outsourced pharma manufacturing heading? Visiongain’s updated report predicts that industry’s revenues from 2013. There you find potentials for sales growth, also understanding trends, technologies for drugs, clients’ needs, and opportunities. That study gives you revenue forecasts to 2023 at overall world market, submarket, and national level. Avoid falling behind, then. Instead see what’s happening for those medical contracting services - outsourcing and off-shoring - finding how you can gain.

Published 11 September 2013

http://www.visiongain.com/Report/1110/Pharma-Contract-Manufacturing-World-Market-Outlook-2013-2023

Pharma Leader Series: Top 25 Biosimilar Drug Manufacturers 2013-2023What does the future hold for makers of biosimilar drugs? Visiongain’s updated report shows you those companies’ prospects to 2023. There you see results, trends, opportunities, and revenue predictions. Our

study analyses 25 leading developers, producers and marketers of biosimilars, also with discussion of other companies. There you find information on established and rising organisations. Discover their sales potentials.

Published 19 September 2013

http://www.visiongain.com/Report/1114/Pharma-Leader-Series-Top-25-Biosimilar-Drug-Manufacturers-2013-2023

Psoriasis Treatment: World Drug Market 2013-2023What’s the future of treating psoriasis? Visiongain’s new report gives you revenue predictions from 2013, helping you stay ahead. There you see financial results, R&D trends, opportunities, and potential revenues. Avoid falling behind, then, missing business or losing influence. In our new report you see forecasted sales to 2023 at overall world market, submarket, product, and national level. You also assess technologies, competitive forces and expected products. Read on to explore that industry and see what its future market could be worth.

Published 05 August 2013

http://www.visiongain.com/Report/1108/Psoriasis-Treatment-World-Drug-Market-2013-2023

Asthma and COPD Therapies: World Market 2013-2023See what the future holds for asthma and COPD therapies. Visiongain’s report gives you drug revenue

predictions to 2023. You find data, trends, opportunities and commercial prospects. That new study lets you assess forecasted sales at overall world market, submarket, product, company and national level. You see why

the asthma and COPD market will grow, as we predict.

Published 06 September 2013

http://www.visiongain.com/Report/1109/Asthma-and-COPD-Therapies-World-Market-2013-2023

Orphan Drugs for Cancer: R&D and Market 2013-2023What’s the future of orphan medicines to treat cancers? Visiongain’s new report gives you revenue predictions from 2013. There you explore results, R&D, opportunities, and potential sales. Orphan drugs can be profitable. In our analysis you see forecasted sales to 2023 at overall world market, submarket, product, and national level. You see the potential of treatments for rare cancers. Try our report now, helping you stay ahead.

Published 29 July 2013

http://www.visiongain.com/Report/1090/Orphan-Drugs-for-Cancer-R-D-and-Market-2013-2023

Stem Cell Technologies: World Market Outlook 2013-2023What are the commercial prospects for stem cells? Visiongain’s updated report predicts revenues to 2023. There you find the best places for sales growth, also understanding trends, technologies, therapies, and opportunities.

That study gives you revenue forecasts to 2023 for the overall world market and its submarkets. See what’s happening for those cellular technologies, finding how you can gain.

Published 02 August 2013

http://www.visiongain.com/Report/1092/Stem-Cell-Technologies-World-Market-Outlook-2013-2023

Biomarkers: Technological and Commercial Outlook 2013-2023What’s the outlook for biomarkers? Visiongain’s updated report predicts revenues to 2023. There you find the best places for sales growth, also understanding trends and opportunities. That study gives you revenue forecasts to 2023 at overall world market, submarket, and national level. See what’s happening for those technologies, finding how you can gain.

Published 23 July 2013

http://www.visiongain.com/Report/1086/Biomarkers-Technological-and-Commercial-Outlook-2013-2023

World Pain Relieving Drug Market 2013-2023

See what the future holds for painkillers. Visiongain’s report gives you revenue predictions to 2023. You find data, trends, opportunities and commercial prospects. That new study lets you assess forecasted sales at overall

world market, submarket, product and national level. You see why the pain relievers industry and market will grow, as we predict.

Published 24 July 2013

http://www.visiongain.com/Report/1088/World-Pain-Relieving-Drug-Market-2013-2023

Biosimilar Monoclonal Antibodies: World Market Prospects 2013-2023What does the future hold for biosimilar therapeutic antibodies? Visiongain’s new report predicts revenues to 2023. There you find the best places for sales growth, also understanding trends and opportunities. In that study you get revenue forecasts at overall world market, submarket, product, and national level. See what’s happening for those technologies, finding how you can gain.

Published 10 July 2013

http://www.visiongain.com/Report/1080/Biosimilar-Monoclonal-Antibodies-World-Market-Prospects-2013-2023

Inflammatory Bowel Diseases: World Drug Market 2013-2023

What’s the future for treating inflammatory bowel diseases (IBD)? Visiongain’s updated report gives you revenue predictions from 2013, helping you stay ahead. There you find financial results, R&D trends,

opportunities, and potential revenues. In that work you see forecasted sales to 2023 at overall world market, submarket, product, and national level. You also assess emerging technologies.

Published 18 July 2013

http://www.visiongain.com/Report/1084/Inflammatory-Bowel-Diseases-World-Drug-Market-2013-2023

Pharma Leader Series: Top Pharma Contract Manufacturing Organisations (CMOs) 2013-2023How are pharma contract manufacturing organisations (CMOs) performing? Visiongain’s new report shows you their prospects to 2023. There you see results, trends, opportunities, and revenue predictions. Our study analyses 30 leading CMOs. There you discover how revenues from drug production services can increase. That way you find information you need on established and emerging companies.

Published 01 July 2013

http://www.visiongain.com/Report/1076/Pharma-Leader-Series-Top-Pharma-Contract-Manufacturing-Organisations-(CMOs)-2013-2023

Pharma Leader Series: Top 50 Generic Drug Manufacturers 2013-2023

What does the future hold for makers of generic drugs? Visiongain’s updated report shows you their prospects to 2023. There you see results, trends, opportunities, and revenue predictions. Our study analyses 50 leading generics producers and marketers. There you find information on established and rising companies. Discover

their sales potentials.

Published 04 July 2013

http://www.visiongain.com/Report/1079/Pharma-Leader-Series-Top-50-Generic-Drug-Manufacturers-2013-2023

Alzheimer’s Disease Therapeutics and Diagnostics: World Market 2013-2023

Where’s treatment of Alzheimer’s disease heading? Visiongain’s new report gives you revenue predictions for those drugs and diagnostic tests from 2013, helping you stay ahead. There you find financial data, R&D trends, opportunities, and prospects. In particular, you see forecasted sales to 2023 at overall world market, submarket, product, and national level.

Published 17 June 2013

http://www.visiongain.com/Report/1068/Alzheimer’s-Disease-Therapeutics-and-Diagnostics-World-Market-2013-2023

Hepatitis Drugs and Vaccines: World Market 2013-2023Where are hepatitis medicines going? Visiongain’s updated report predicts revenues there from 2013 to 2023. It also explains trends in that business and technology - with prospects and opportunities - to help your work.

In that study you gain sales forecasts at overall world market, submarket, product, and national level. See what’s happening. Also discover what has most growth potential.

Published 21 June 2013

http://www.visiongain.com/Report/1071/Hepatitis-Drugs-and-Vaccines-World-Market-2013-2023

Single-Use Bioreactors for Pharma: World Market 2013-2023

Where’s the single-use bioreactors market heading? How are these products performing? Visiongain’s updated report gives you forecasted revenues there to 2023 and also explains R&D trends, outlooks and commercial opportunities. Our study lets you assess sales data and predictions for the world single-use bioreactors market, submarkets, important products and national markets. Those analyses show you that pharmaceutical field’s most promising and lucrative segments.

Published 03 June 2013

http://www.visiongain.com/Report/1057/Single-Use-Bioreactors-for-Pharma-World-Market-2013-2023

Leading Anti-Cancer Drugs and Associated Market 2013-2023Do you want to assess the future of cancer medicines? Visiongain’s updated report gives you revenue

predictions there from 2013, helping you stay ahead. You find financial data, R&D trends, opportunities, and outlooks. In that work you see forecasted sales to 2023 at overall world market, submarket, product, and

national level. You also assess emerging trends, technologies, and expected drugs.

Published 11 June 2013

http://www.visiongain.com/Report/1063/Leading-Anti-Cancer-Drugs-and-Associated-Market-2013-2023

World Biological Drugs Market 2013-2023

Do you want to find sales potentials of biological drugs? Visiongain’s updated report gives you revenue predictions for biologics from 2013, helping you stay ahead. There you find financial data, R&D trends, opportunities, and discussions of prospects. In that work you see forecasted sales to 2023 at overall world market, submarket, product, and national level. You also assess emerging trends, technologies, and expected products.

Published 13 May 2013

http://www.visiongain.com/Report/1048/World-Biological-Drugs-Market-2013-2023

Pharma Wholesale and Distribution Market: World Outlook 2013-2023Where’s the drug wholesaling and distribution market heading? Visiongain’s updated report predicts revenues

there from 2013 to 2023. It also explains trends in business and technology, prospects, and opportunities to help your work. In that study you gain sales forecasts at overall world market, submarket, company, and

national level.

Published 03 June 2013

http://www.visiongain.com/Report/1056/Pharma-Wholesale-and-Distribution-Market-World-Outlook-2013-2023

Rheumatoid Arthritis (RA): World Drug Market 2013-2023

Where’s the arthritic treatment market heading? Visiongain’s updated report gives you forecasted revenues to 2023 for drugs treating human rheumatoid arthritis (RA). There you find R&D trends, outlooks and commercial opportunities. Our study lets you assess sales data and predictions for the world RA medicines market, therapeutic submarkets, products and national markets. Those analyses show you that pharmaceutical field’s most promising and lucrative segments. Established and emerging anti-rheumatic technologies have potential. Read on to scan features of that industry, find what drives it, and see what its future market could be worth.

Published 19 April 2013

https://www.visiongain.com/Report/1029/Rheumatoid-Arthritis-(RA)-World-Drug-Market-2013-2023

Diabetes Treatments: World Drug Market 2013-2023Where’s the diabetic treatments market heading? How are those products performing? visiongain’s updated report gives you forecasted revenues there to 2023 and also explains R&D trends, outlooks and commercial

opportunities. Our study lets you assess sales data and predictions for the world antidiabetic medicines market, therapeutic submarkets, products and national markets. Those analyses show you that pharmaceutical field’s

most promising and lucrative segments. Established and emerging diabetes-treating drugs have potential. Read on to scan features of their industry, find what drives it, and see what its future market could be worth.

Published 24 April 2013

https://www.visiongain.com/Report/1033/Diabetes-Treatments-World-Drug-Market-2013-2023

Small-Molecule Targeted Cancer Therapies: World Market 2013-2023What does the future hold for small targeted agents to treat cancers? Visiongain’s updated report gives you revenue predictions to 2023. There you find sales data, R&D trends, opportunities and commercial prospects. You see the potential of those molecularly-targeted technologies and products. Our new analysis lets you assess forecasted sales at overall world market, product and national level. Discover how and why revenues can increase.

Published 10 December 2012

http://www.visiongain.com/Report/948/Small-Molecule-Targeted-Cancer-Therapies-World-Market-2013-2023

Pharma Clinical Trial Services: World Market 2013-2023What’s the outlook for clinical research providers? Visiongain’s updated report gives you forecasted revenues to 2023. It explains trends, opportunities and commercial prospects. Our study lets you assess sales data at overall

world market, submarket and national level. There you find the most promising and lucrative areas in clinical trial outsourcing, helping your research and analyses.

Published 25 January 2013

http://www.visiongain.com/Report/973/Pharma-Clinical-Trial-Services-World-Market-2013-2023

Pharma Leader Series: Top 20 Ophthalmic Drug Manufacturers 2012-2022What does the future hold for top companies in the pharma ophthalmics industry? Visiongain’s new report shows you their prospects to 2022. You find financial data, trends, opportunities and revenue predictions. We analyse 29 leading companies for eye medicines, to help you see the future of that industry and market. Discover how sales of ocular drugs can increase.

Published 16 October 2012

http://www.visiongain.com/Report/911/Pharma-Leader-Series-Top-20-Ophthalmic-Drug-Manufacturers-2012-2022

World Pharmaceutical Contract Sales Market 2013-2023Where are pharma contract sales organisations (CSOs) heading? Visiongain’s updated report gives you

forecasted revenues to 2023 for that market and shows you trends, opportunities and industry prospects. For sales outsourcing our study lets you assess projected sales data at overall world market, submarket and

national level.

Published 06 November 2012

http://www.visiongain.com/Report/928/World-Pharmaceutical-Contract-Sales-Market-2013-2023

Pharma Leader Series: Top 20 Biological Drug Manufacturers 2012-2022How are companies in the biological medicines (biologics) industry performing? Visiongain’s new report shows

you organisations’ prospects to 2022. There you find financial data, trends, opportunities and commercial potentials. We assess 20 leading developers and producers of biological drugs and vaccines - our analyses help

you see the future of the biopharma industry and market.

Published 10 September 2012

http://www.visiongain.com/Report/889/Pharma-Leader-Series-Top-20-Biological-Drug-Manufacturers-2012-2022

Pharmaceutical Contract Manufacturing: World Market Outlook 2012-2022How does the future look for pharmaceutical contract manufacturing? Visiongain’s report gives you sales predictions to 2022. You find data, trends, opportunities and commercial prospects. In our investigation you find revenue forecasting, growth rates and market shares. Also, you see qualitative analyses, including discussions of regulatory and commercial developments.

Published 20 August 2012

http://www.visiongain.com/Report/880/Pharmaceutical-Contract-Manufacturing-World-Market-Outlook-2012-2022

Neuroprotective Products: World Market Prospects 2012-2022What are the commercial prospects for neuroprotective treatments? Visiongain’s new report shows you potential revenues and trends to 2022, discussing data, opportunities and outlooks. Many neuroprotective products are in development. Our study lets you assess projected sales at overall world market, therapeutic submarket and product level to 2022. In particular, how will 11 products - including Rasagiline, Minocycline, Memantine and NeuroSTAT - perform to 2022?

Published 10 May 2012

http://www.visiongain.com/Report/819/Neuroprotective-Products-World-Market-Prospects-2012-2022

Pharma Leader Series: Top 20 Antibacterial Drug Manufacturers 2012-2022

How are leading companies in the antibacterial drugs market performing? Visiongain’s new report gives you data, analyses and revenue predictions for antibacterial manufacturers. See how top companies worldwide are

performing and where they are heading. You assess their technologies, products and commercial prospects to 2022.

Published 21 June 2012

http://www.visiongain.com/Report/841/Pharma-Leader-Series-Top-20-Antibacterial-Drug-Manufacturers-2012-2022

Multiple Sclerosis Treatment: World Drug Market 2012-2022What are the commercial prospects for multiple sclerosis treatment? Discover revenue predictions for multiple sclerosis (MS) treatments at world market, product and national levels to 2022. How will the drugs Copaxone,

Avonex, Rebif, Betaseron/Betaferon, Tysabri, Extavia and Gilenya perform to 2022?

Published 23 November 2011

http://www.visiongain.com/Report/723/Multiple-Sclerosis-Treatment-World-Drug-Market-2012-2022

SOON TO BE PUBLISHED TOPICS

Allergic Rhinitis Drugs Market Forecast 2014-2024: Prospects for Leading Companies

Pain Relieving Drugs Market Forecast 2014-2024

Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast 2014-2024: Opportunities for Leading Companies

ABOUT VISIONGAIN PHARMA REPORTS

In our analytical reports we cover a wide range of industries and markets in healthcare. We show you future prospects for many commercial areas:

• Novel branded pharmaceuticals – therapeutic applications and drug classes

• Biopharmaceuticals (biologics) and healthcare biotechnology, including drug delivery and other technologies

• Generic drugs, the pharma supply chain and over-the-counter (OTC) medicines

• Outsourced services – clinical trials, pharma manufacturing and other roles

• Diagnostic tests and instruments

• Medical devices – implants and other products.

There you find revenue forecasts. Our reports analyse and explain commercial prospects at overall world, submarket, national and product level, suiting the topics.

That way, you assess opportunities and commercial potentials for healthcare industries and markets. We pack our reports with information to help your work and save you time:

• Access to present and predicted trends, harnessing years of analytical experience and knowledge

• Data and discussions – including our 10-year revenue forecasts – for your research, analyses and decision making

• Tables, charts and lists to benefit your reports, proposals and presentations.

In our investigations you find revenue forecasting, growth rates and market shares. You see qualitative analyses (SWOT and STEP), R&D and commercial news too. We also show you interviews with authorities. You see opinions from our surveys.

The reports harness company and industry literature, outside experts, surveys, public health data and policy documents. You find discussions of technological, commercial and economic issues, with emphasis on competing organisations. Discover their prospects, including reviews of companies.

In addition to covering worldwide markets, our analysts show you revenue forecasts and other information for leading national markets. Examples include the US, Japan, Germany, France, the UK, Spain, Italy (EU5), India and China.

Our studies give you analysis from primary and secondary research. You receive information found only in our work – quantitative and qualitative analyses with independent predictions.

Many commercial opportunities exist. We show you where these are and explain their significance and potential from this decade onwards. You find knowledge to help you stay ahead.

We look forward to meeting your business intelligence needs for healthcare. Please let us help your work now.

To see all visiongain pharma reports please visit http://www.visiongain.com/Sector/8/Pharma

MORE INFORMATIONContact Ediz Ibrahim ediz.ibrahim@visiongainglobal.com+44 (0) 20 7549 9976

VISIONGAIN LICENCES

Single User License

This license allows for use of a report by one named person. This person may use the report, and may print out the report, but may not share the report (or any information contained therein) with any other person or persons. Unless a Departmental License, a Site License or a Global Site License is purchased, a Single User License must be purchased for every person that wishes to use the report within the same enterprise.

Customers who infringe these licence terms are liable for a Global Site licence fee.

Departmental Licenses

This license allows for use of a report by five people within the same enterprise location. Each of these people may use the report, and may print out the report, but may not share the report (or any information contained therein) with any other person or persons.

Customers who infringe these licence terms are liable for a Global Site licence fee.

Site License

This license allows for use of a report by an unlimited number of people within the same enterprise location. Each of these people may use the report on any computer, and may print out the report, but may not share the report (or any information contained therein) with any person or persons outside of the enterprise location.

Customers who infringe these licence terms are liable for a Global Site licence fee.

Global License

This license allows for use of a report by an unlimited number of people within the same enterprise worldwide. Each of these people may use the report on any computer, and may print out the report, but may not share the report (or any information contained therein) with any other person or persons outside of the enterprise.

Yes, I want to purchase the report below

Report title ...............................................................................

.................................................................................................

.................................................................................................

Report licenses (please tick box)

Single user £1499 / £1549 / £1699 / £1799 (plus 20% VAT)

Departmental (five users) £2999 (plus 20% VAT)

Site (one location) £4999 (plus 20% VAT)

Global £6999 (plus 20% VAT)

PHARMA REPORT SALES ORDER FORM Fax back to: +44 (0) 207 549 9930

Contact Information

First Name .................................................................................... Last Name ..................................................................................

Job Title .............................................................................................................................................................................................

Company Name .................................................................................................................................................................................

Address .............................................................................................................................................................................................

City ............................................................ Postcode .................................................... Country .....................................................

Tel ................................................................................................ Fax .............................................................................................

E-mail ................................................................................................................................................................................................

End-user Email(s) – If different from above .......................................................................................................................................

...........................................................................................................................................................................................................

EU members are VAT exempt if VAT number is provided.

EEC VAT Number (EU Only) ............................................ Signature .....................................................................................

VISIONGAIN LTD - 230 City Road, London, EC1V 2QY, UK - Registration Number: 3626739

Payment Information (please select)

Paying by Credit Card

Please select as appropriate Visa MasterCard American Express Other CC

Card No

Expiry Date

Security No

Issue No

Paying by Invoice (Bank transfer or Cheque)

Visiongain LtdBarclays Bank PLCPiccadilly Branch48 Regent StreetLondon, W1B 5RA, UK

A/C: Visiongain LtdSort Code: 20-71-64Account No: 6038 7118Swift Code: BARC GB22IBAN: GB80 BARC 20716460387118